On Your Radar > Consolidation

Email this page News by email Send a press-release

Consolidation

The pharmaceutical industry seems besieged on all sides by declining R&D productivity, expiring patents and relentless downward pricing pressure. One effect of this onslaught has been an upsurge in the level of consolidation as industry players attempt to cut costs, expand research pipelines and lengthen geographic reach.

Borgas sets out ‘top 8’ pharma industry issues

23-Oct-2008 - The pharmaceutical industry must adapt its processes and strategies to cope with a new, tougher operating environment, according to Stefan Borgas, CEO of Lonza.

WuXi, Covance split before deal is consummated

06-Oct-2008 - The much-trumpeted partnership between China’s WuXi PharmaTech and Covance to provide ‘world class preclinical research services’ has been called off.

Encorium backs away from Prologue deal

30-Sep-2008 - US contract research organisation Encorium Group has postponed its planned acquisition of Prologue Research International and cut staff in the latest twist in a rollercoaster ride for the firm in recent weeks.

Moody's down on pharma prospects

25-Sep-2008 - Pharmaceutical companies on both sides of the Atlantic are facing a particularly difficult time over the next 12 to 18 months, according to a report by financial research and analysis company Moody’s.

India’s Lupin buys into southern Africa

25-Sep-2008 - Indian pharmaceutical company Lupin Ltd has expanded into Africa by acquiring a 60 per cent stake Pharma Dynamics, a generics company and contract manufacturer based in Cape Town, South Africa.

Acquisition looming in Calyx Pharma’s future, says CEO

22-Sep-2008 - Active pharmaceutical ingredient specialist Calyx Chemicals and Pharmaceuticals is planning an acquisition within the next two years, probably in the US or Europe, according to chief executive Smitesh Shah.

Quintiles gets bigger in Singapore to continue Asian push

15-Sep-2008 - Quintiles Transnational Corp has announced an expansion of its operations in Singapore in order to meet what it described as “surging demand” in the Asia-Pacific region.

Parexel feels effects of adding ClinPhone

11-Sep-2008 - Parexel has trimmed back its earnings guidance for the first quarter of fiscal 2009 as it starts the process of integrating ClinPhone, which the company bought for £91m (€114m) last month.

Tripos looks to the future with Pharsight acquisition

11-Sep-2008 - Drug discovery informatics and services provider, Tripos International, has agreed to buy Pharsight Corporation, a provider of software and strategic services for clinical drug development.

Merger beefs up German CMO Haupt Pharma

10-Sep-2008 - Haupt Pharma has completed its merger with fellow German companies Amareg and Wülfing Pharma to create a major new force in the European contract development and manufacturing sector, with around 1,500 staff and an annual turnover of €180m.